Patients have a voice – Five highlights from the Eupati Nordic Workshop

In future, patient involvement and the patients’ “voice” will have an increasingly important role.


Great results from our client satisfaction survey

We were particularly thanked for service-mindedness and meeting the agreed timelines as well as for co-operation fostering our clients’ business goals.


Returnee strengthens the DRA team

DRA has also been joined by a “returnee”, Eija Kinos.


DRA Consulting Oy wants to help fight the climate change

This year we made a donation to the Finnish Association for Nature Conservation in their climate protection work.


ISPOR Europe: More transborder co-operation between the authorities is needed in medicines evaluation and health technology assessment

Co-operation can produce high-quality and topical scientific reports, transparent processes and clear requirements for the evidence required.


Meet us at #ISPOREurope

Join us in Copenhagen on 2-6 November 2019! Drop by booth #C2-011 and have a chat with us.


TOPRA 2019: Technology poses challenges to the regulatory world – patient involvement is pursued

Is Europe prepared to assess medicines based on new technologies or novel innovations, or different types of study data?


TOPRA is approaching – See you there!

Meet us at the TOPRA Annual Symposium on 30 September – 2 October 2019 in Dublin, Ireland.


New EMA guidance on management of medicine shortages

EMA has published guidance to marketing authorisation holders and authorities to improve and harmonise management of medicine shortages and related reporting and communication.


Information about shortages does not reach prescribers – call for developers of communication voiced at the DRA expert event

The expert event brought together more than 50 representatives of the pharma industry and medicinal wholesalers to exchange experiences and thoughts on how to control availability of medicines.


Pauliina Lajunen appointed as Chief Operative Officer of DRA Consulting: “Towards new challenges via a genetic test”

Pauliina Lajunen will help boost DRA’s growth and internationalization with her business and marketing expertise. Welcome Pauliina!


Risk management materials and clinical work – do they meet?

Availability of risk management materials and electronic systems were much-discussed topics at the traditional pharmacovigilance seminar in Oslo.

1 2 3 4 5 6 15